跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Combetzar - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Combetzar
Approved
STANDARD
Combetzar
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
74d21210942353e5
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
74d21210942353e5
Drug Approval Philippines Name
Combetzar
Product Name
Combetzar
Registration Number
DRP-2149-01
Brand Name
Combetzar
Generic Name
Losartan Potassium + Hydrochlorothiazide
Dosage Form
Film - Coated Tablet
Dosage Strength
50 mg/12.5 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Suhitas Pharmaceuticals, Inc.
Distributor
Better Option Pharmaceuticals, Inc.
Issuance Date
25 February 2025
Expiry Date
24 February 2037
Pharmacologic Category
Angiotensin II Receptor Blocker (ARB)/Diuretic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
74d21210942353e5
Type
Standard
Back to Philippines FDA Approvals